AbInitio Bio
AbInitio Bio develops AI foundation models for biologic drug manufacturability and process optimization.
Source: ycombinator.com
Latest round on record: Pre Seed, May 2026, amount undisclosed.
All 2 rounds ↓Signals
Website registeredDec 17, 2025 (11 months old)
Funding rounds
- Pre Seed · amount undisclosed
- Website created
- Date unknownRound · $500K*Source: ycombinator.com
Founders and team
DM
Daniel Mukasa FounderNG
Nisha Gopal Founder
Investors
Companies like AbInitio Bio
RRed Arrow TXGGrove Biopharma$30M Series A · Apr 2025
EEmulsi BiotechPre Seed · Jun 2026
TTileBio$2.15M Seed · Mar 2026
OOutpost Bio$3.5M Series B+ · Mar 2026
PPeregrine Bio
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/abinitio-bio (get a free API key).